173 to 1: Bris­tol-My­ers chief Caforio picked up a $19.4M com­pen­sa­tion deal af­ter lead­ing the charge for $74B Cel­gene buy­out

Bris­tol-My­ers Squibb went right down to the wire on its proxy state­ment. And just days af­ter in­vestors pro­vid­ed a stamp of ap­proval for its huge $74 bil­lion Cel­gene buy­out, the big bio­phar­ma out­fit dis­closed the top pay it pro­vid­ed to its ex­ec­u­tive team.

CEO Gio­van­ni Caforio led the way up in 2018, grab­bing a com­pen­sa­tion pack­age val­ued at $19.4 mil­lion, an in­crease over the $18.7 mil­lion record­ed for 2017. It’s al­so in line with his pace for the last few years, with 2016 com­pen­sa­tion com­ing in at just un­der $17 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER